Familial Mediterranean fever: a critical digest of the 2012-2013 literature

Eisenstein, E.M.; Berkun, Y.; Ben-Chetrit, E.

Clinical and Experimental Rheumatology 31(3 Suppl. 77): 103-107

2013


ISSN/ISBN: 0392-856X
PMID: 24064023
Document Number: 668185
The year 2012-2013 has been a fertile one in the area of FMF inquiry. Recent studies have led to further insight into the possible mechanisms whereby pyrin mutations might cause the auto-inflammatory phenotype that is characteristic of FMF. Evidence-based guidelines for diagnosis of FMF, including the role of genetic testing, have become available. Risks for colchicine resistance have been partially defined, and a randomised, controlled trial showing efficacy of an interleukin-1 antagonist for treatment of colchicine-resistant or intolerant FMF patients was reported. In this review, we summarise these and other salient findings from the recent FMF literature, and discuss their significance for the clinician.

Document emailed within 1 workday
Secure & encrypted payments